MAGINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 2.651
EU - Europa 2.040
AS - Asia 1.517
SA - Sud America 340
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.583
Nazione #
US - Stati Uniti d'America 2.600
SG - Singapore 571
IE - Irlanda 391
IT - Italia 362
UA - Ucraina 350
BR - Brasile 291
HK - Hong Kong 291
CN - Cina 280
RU - Federazione Russa 205
DE - Germania 177
VN - Vietnam 135
SE - Svezia 127
FI - Finlandia 123
GB - Regno Unito 95
FR - Francia 71
KR - Corea 69
TR - Turchia 56
CA - Canada 28
IN - India 24
BE - Belgio 21
NL - Olanda 21
PL - Polonia 20
AR - Argentina 17
ES - Italia 16
UZ - Uzbekistan 16
AT - Austria 15
MX - Messico 15
ZA - Sudafrica 15
CH - Svizzera 13
IR - Iran 13
EC - Ecuador 10
JP - Giappone 9
LT - Lituania 8
PK - Pakistan 8
PY - Paraguay 8
RO - Romania 8
CO - Colombia 7
MY - Malesia 7
IQ - Iraq 6
LB - Libano 6
CZ - Repubblica Ceca 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
GR - Grecia 4
EG - Egitto 3
EU - Europa 3
ID - Indonesia 3
MA - Marocco 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
IL - Israele 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.583
Città #
Chandler 469
Dublin 391
Singapore 354
Hong Kong 289
Jacksonville 187
San Mateo 184
Ashburn 150
Perugia 141
Boardman 137
Ann Arbor 104
Santa Clara 101
Medford 89
Beijing 88
Princeton 88
Dong Ket 69
Wilmington 69
Seoul 68
Munich 66
Moscow 60
Altamura 56
Andover 47
Los Angeles 44
Lawrence 38
São Paulo 37
Des Moines 36
Izmir 34
New York 30
Helsinki 27
Saint Petersburg 25
Ho Chi Minh City 23
Brussels 20
Piscataway 20
Florence 19
Woodbridge 18
Atlanta 17
Frankfurt am Main 17
Norwalk 16
Brooklyn 14
Denver 14
Hanoi 13
Rome 13
Turku 13
Shanghai 12
Johannesburg 11
Seattle 11
Warsaw 11
Belo Horizonte 10
Houston 10
Poplar 10
Porto Alegre 10
Rio de Janeiro 10
San Paolo di Civitate 10
The Dalles 10
Toronto 10
Boston 9
Chicago 9
Falkenstein 9
Isfahan 9
Tokyo 9
Çankaya 9
Dallas 8
Dronten 8
Falls Church 8
Milan 8
San Francisco 8
Washington 8
Brasília 7
Edinburgh 7
Kuala Lumpur 7
Manchester 7
Montreal 7
Nuremberg 7
Redwood City 7
Amsterdam 6
Ankara 6
Auburn Hills 6
Chennai 6
Columbus 6
Mexico City 6
Redmond 6
San Diego 6
Council Bluffs 5
Curitiba 5
Guarulhos 5
London 5
Naples 5
Salvador 5
Asunción 4
Bexley 4
Den Haag 4
Shenyang 4
Stockholm 4
Tappahannock 4
Taranto 4
Tashkent 4
Timisoara 4
Aracaju 3
Bari 3
Betim 3
Biên Hòa 3
Totale 4.097
Nome #
FORMULAZIONE E CARATTERIZZAZIONE DI NUOVI TIPI DI NANOPARTICELLE PER STRATEGIE DI “DRUG DELIVERY” A LIVELLO CEREBRALE 135
Carbon dioxide capture by immobilized carbonic anhydrase 122
Identification and characterization of mature beta-hexosaminidases associated with human placenta lysosomal membrane 119
Alternative splicing mechanisms orchestrating post-transcriptional gene expression: intron retention and the intron-rich genome of apicomplexan parasites 113
System biology of stress response addressed by FTIR analysis of whole yeast cells 111
Methods to Discriminate the Distribution of Acidic Glycohydrolases Between the Endosomal–Lysosomal Systems and the Plasma MembraneEndosome Signaling Part A 105
beta-hexosaminidase over-expression affects glycosphingolipid metabolism in mammalian cells-52° Congresso SIB 104
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 104
Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery 97
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 96
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 96
Assessment of safety and efficiency of nitrogen organic fertilizers from animal-based Protein Hydrolysates - a laboratory multidisciplinary approach 95
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenesis Type II Fibroblasts 94
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 94
Extending lifespan through autophagy stimulation: a future perspective 91
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 89
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 88
Acidic glycohydrolases localization and regulation: pathological implication 88
Oncogenic H-Ras Up-Regulates Acid β-Hexosaminidase by a Mechanism Dependent on the Autophagy Regulator TFEB 88
Curcumin Analogue C1 Promotes Hex and Gal Recruitment to the Plasma Membrane via mTORC1-Independent TFEB Activation 88
Jurkat T-cell stimulation up-regulates the expression of lysosomal β-hexosaminidase and β-galactosidase and triggers their recruitment to lipid microdomains 87
Human plasma membrane associated B-hexosaminidase A Hydrolizes GM2 ganglioside 85
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 85
RAPAMYCIN LOADED SOLID LIPID NANOPARTICLES: FORMULATION, CHARACTERIZATION AND INHIBITION OF mTORC1 ACTIVITY IN SH-SY5Y NEUROBLASTOMA CELLS. 85
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard 85
New perspectives for the diagnosis of Alzheimer's disease. 84
2D-Electrophoretic analysis for Alzheimer's Disease early marker identification in peripheral cells 84
NANOPARTICLE-DRIVEN DRUG DELIVERY TO THE CNS: COMPARISON OF PLGA AND LIPID-BASED NAOPARTICLES IN MOUSE MODEL OF NEURODEGENERATIVE DISEASES 84
Proteome Alterations in Equine Osteochondrotic Chondrocytes 84
Identification of plasma membrane associated mature B-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts 83
FIBROBLASTS FROM PS1 MUTATED PRE-SYMPTOMATIC SUBJECTS AND ALZHEIMER’S DISEASE PATIENTS SHARE A UNIQUE PROTEIN LEVELS PROFILE. 83
Glycohydrolases β-hexosaminidase and β-galactosidase are associated with lipid microdomains of Jurkat T-lymphocytes 83
Cells over-expressing Ras show modulation of lysosomal enzymes activity 82
Cellular Redox Imbalance and Changes of Protein S-glutathionylation Patterns Are Associated with Senescence Induced by Oncogenic H-Ras 81
Changes in Lipid Composition During Manganese-Induced Apoptosis in PC12 Cells 80
Functional metaproteome analysis of microbial populations in enrichment cultures on polycyclic aromatic hydrocarbons 78
Effect of pH on potassium metabisulphite biocidic activity against yeast and human cell cultures 78
Identification and characterization of a fully processed beta-hexosaminidase isoform associated to lysosomal membrane-52° Congresso SIB 77
Human lysosomal α-D-mannosidase regulation in promyelocytic leukaemia cells. 77
PROTEIN EXPRESSION PROFILE OF PLASMEPSIN IV KNOCK DOWN PLASMODIUM BERGHEI PARASITE AND IMMUNOREACTIVE IDENTIFICATION 77
Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity 76
Rapamycin-loaded solid lipid nanoparticles for brain targeting 76
Drug delivery strategies for mTOR inhibitors therapy in neurodegenerative and neuro-oncologic disease. 76
Plasma membrane β-galactosidase and β-hexosaminidase are associated to lipid raft of Jurkat T-cell upon raft clustering. 75
Carbon dioxide capture at gas emission site by carbonic anhidrase 75
Transcriptional regulation of glycosphingolipids degrating enzymes 75
Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update 75
Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways 74
Potassium metabisulfite treatement alters human fibroblast protein expression pattern. 74
Effect of potassium metabisulfite in human fibroblast. 74
β-Hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells 74
Metagenomic and Metaproteomic Characterization of Enrichment Cultures on Polycyclic Aromatic Hydrocarbons 73
Evidence of tRNA cleavage in apicomplexan parasites: Half-tRNAs as new potential regulatory molecules of Toxoplasma gondii and Plasmodium berghei 73
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 72
Enzymes for capturing greenhouse gases: use of immobilized carbonic anhydrase to develop a bioreactor subtracting carbon dioxide from mixed gas streams 71
Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts 71
Plasma membrane associated beta-hexosaminidase: biological significance and regulation 69
TFEB overexpression promotes the translocation of lysosomal glycohydrolases beta-hexosaminidase and beta-galactosidase to cell surface lipid microdomains 69
Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization 69
Expression of the glycolytic enzymes enolase and lactate dehydrogenase during the early phase of Toxoplasma differentiation is regulated by an intron retention mechanism 68
Evidence for the presence of human B-hexosaminidase B as lysosomal membrane associated protein 67
TFEB activation promotes the recruitment of lysosomal glycohydrolases β-hexosaminidase and β-galactosidase to the plasma membrane 67
Glycosphingolipid metabolism is affected by beta-hexosaminidase over-expression in mammalian cells 64
hLGDB: a database of human lysosomal genes and their regulation 64
Ras differentially regulates lysosomal enzymes expression 64
Identification of lysosomal membrane associated, fully processed beta-hexosaminidase enzyme 63
Derivatized nanoparticle for CSN-target drug delivery 62
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model 61
Ras mutants specifically regulates lysosomal glycohydrolases activity in different cell models. 60
Cellular redox imbalance and S-glutathionylation of target proteins promote senescence induced by oncogenic H-Ras. 60
Modified PLGA-NPS able to cross the blood-brain barrier for the delivery of lysosomal enzymes in llysosomal storage disease 60
Proteome characterization of a microbial community response to polycyclic aromatic hydrocarbons exposure. 60
β-Hexosaminidase α-subunit overexpression affects lipid microdomain glycohydrolases content 59
Rapamycin-loaded solid lipid nanoparticles: morphology and impact of the drug loading on the phase transition between lipid polymorphs 59
Solid lipid nanoparticle as a tool to deliver mTOR inhibitors 58
Plasma membrane associated beta-hexosaminidase activity during human T-cells activation 57
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 56
A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer’s Disease and Other Neurological Disorders 55
RECENT DEVELOPMENTS IN THERAPEUTIC APPROACHES FOR LYSOSOMAL STORAGE DISORDERS 53
Signaling Pathways in Exosomes Biogenesis, Secretion and Fate 52
Ras differentially regulates lysosomal enzymes expression 52
Everolimus treatment reduces proliferation of TSC1-deficient adult neural stem/progenitor cells and restores their migration capability. 51
Occurrence of an anomalous endocytic compartment in fibroblasts from Sandhoff disease patients 51
Recruitment of plasma membrane β-galactosidase and β-hexosaminidase in lipid rafts upon T-cell activation 50
Intrathecal administration of mTOR inhibitors for the therapy of neurodegenerative, neuroinflammatory and neurooncologic diseases 50
Regulation of lysosomal genes by miRNA 47
Hypermethylation contributes to down-regulation of lysosomal β-hexosaminidase α subunit in prostate cancer cells. 46
null 45
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins. 42
Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells 41
Proteome characterization of a microbial community response to polycyclic aromatic hydrocarbons exposure 34
null 14
Totale 6.842
Categoria #
all - tutte 33.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 226 26 53 4 84 16 60 77
2021/2022676 11 119 17 23 19 4 11 231 15 21 84 121
2022/20231.351 98 232 11 122 127 143 0 52 493 3 56 14
2023/2024602 55 32 44 13 7 13 139 9 74 12 107 97
2024/20251.298 27 130 50 122 164 68 20 81 210 58 239 129
2025/20261.250 198 204 192 482 174 0 0 0 0 0 0 0
Totale 6.842